156 related articles for article (PubMed ID: 27187735)
1. IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CT.
Krebs S; Monti S; Seshan S; Fox J; Mannelli L
Clin Nucl Med; 2016 Aug; 41(8):e388-9. PubMed ID: 27187735
[TBL] [Abstract][Full Text] [Related]
2. IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
Vadi SK; Parihar AS; Kumar R; Singh H; Mittal BR; Bal A; Sinha SK
Clin Nucl Med; 2018 Jul; 43(7):e247-e249. PubMed ID: 29762245
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT Features of Chronic Sclerosing Sialadenitis Presenting as Localized IgG4-Related Disease.
Kashiwagi N; Enoki E; Hosokawa C; Sakaguchi K; Murakami T
Clin Nucl Med; 2017 Feb; 42(2):131-132. PubMed ID: 28060780
[TBL] [Abstract][Full Text] [Related]
4. IgG4-Related Renal Lesions Detected by Delayed 18F-FDG PET/CT Scan.
Fu Z; Liu M; Zhang J; Li Z; Li Q
Clin Nucl Med; 2017 Jan; 42(1):66-67. PubMed ID: 27764042
[TBL] [Abstract][Full Text] [Related]
5. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
[TBL] [Abstract][Full Text] [Related]
6. IgG4-Related Tubulointerstitial Nephritis Pattern in 18F-FDG PET/CT.
Bélissant O; Guernou M; Rouvier P; Compain C; Bonardel G
Clin Nucl Med; 2015 Oct; 40(10):808-9. PubMed ID: 26204208
[TBL] [Abstract][Full Text] [Related]
7. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
8. Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Lee J; Hyun SH; Kim S; Kim DK; Lee JK; Moon SH; Cho YS; Choe YS; Kim BT; Lee KH
Clin Nucl Med; 2016 May; 41(5):e237-43. PubMed ID: 26914555
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-FDG PET-CT usefulness in extra-pancreatic involvement in IgG4 related diseases.
Cárdenas-Perilla R; Monturiol-Duran J; Simó-Perdigó M; Barios-Profitós M; Castell-Conesa J
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):366-9. PubMed ID: 24630373
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
11. 18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer.
Yamane T; Ueda S; Seto A; Kuji I
Clin Nucl Med; 2018 May; 43(5):379-380. PubMed ID: 29485433
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer and Physiologic Avidity From Breast Feeding on FDG PET/CT.
Ulaner GA
Clin Nucl Med; 2023 May; 48(5):420-421. PubMed ID: 36800273
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
15. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Involvement of IgG4-Related Disease Presenting as Multiple Hypermetabolic Masses on FDG PET/CT.
Pan Q; Wang Y; Luo Y; Ma Y; Li F
Clin Nucl Med; 2018 Oct; 43(10):777-779. PubMed ID: 30106859
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
[TBL] [Abstract][Full Text] [Related]
18. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
19. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT Findings in a Patient With Primary Mucinous Cystadenocarcinoma of the Breast.
Hu Y; Tian C; Zhang X; Wei Q; Bian Y
Clin Nucl Med; 2020 Feb; 45(2):159-160. PubMed ID: 31876834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
